心房颤动心肌NF—κB的表达(2)
 |
| 第1页 |
参见附件。
[参考文献]
[1] Savelieva I，Camm J. Update on arial fibrillation：Part I[J]. Clin Cardiol，2008，31：55-62.
[2] Kannel WB，Benjamin EJ. Status of the epidemiology of atrial fibrillation[J]. Med Clin North Am，2008，92：17-40.
[3] Issac TT，Dokainish H，Lakkis NM. Role of inflammation ininitiation and perpe tuation of atrial fibrillation：A systematic review of the published data[J]. J Am Coll Cardiol，2007，50：20-21.
[4] Engelmann MD，Svendsen JH. Inflammation in the genesisand perpetuation of atrial fibrillation[J]. Eur Heart J，2005，26：83-92.
[5] Chung MK，Martin DO，Sprecher D，et al. C- reactive protein elevation in patients with atrial arrhythmias：Inflammatory mechanisms and persistence of atrial fibrillation[J]. Circulation，2001，14：86-91.
[6] Jacobs MD，Harrison SC. Structure of an IkappaBalpha/NFkappaB complex[J]. Cell，1998，95：49-58.
[7] Von LD，Kockskj MJ，Rubertus SU，et al. Direct proarrhythmo-genie effects of angiotensin lI can be suppressed by AT1 receptor blockade in human atrial myocardium[J]. Eur J Heart Fail，2008，10(12)：72-76.
[8] Ortego M，Bustos C，Hernandez-Presa MA，et al. Atorvastatin reduces NF-kappaBactivation and chemokine expression in vascular smooth muscle cells and mononuclear cells[J]. Atherosclerosis，1999，147：53-61.
[9] Young-Xu Y，Jabbour S，Goldberg R，et al. Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease[J]. Am J Cardiol，2003，92：79-83.
[10] Hitoshi Ichiki(MD)a. The role of infection in the development of non- valvular atrial fibrillation：Up-regulation of Toll-like receptor 2 expression levels on monocytes[J]. Journal of Cardiology，2011，53：27-35.
[11] Aviles RJ，Martin DO，Apperson-Hansen C，et al. Inflammation as a risk factor for atrial fibrillation[J]. Circulation，2003，18：6-10.
[12] Qu YC，Du YM. Activated nuclear factor-kB and increased tumor necrosis factor-a in atrial tissue of atrial fibrillation[J]. Scandinavian Cardiovascular Journal，2010，43：92-97.
(收稿日期：2012-09-10)
您现在查看是摘要介绍页，详见PDF附件(2816kb)。